Positive Patient Stories™
PRTK (common stock) $6.01 $-0.25 628248 See More >>

Our Mission

At Paratek, we provide solutions that enable positive outcomes and lead to positive patient stories. In the end, data isn’t remembered. Stories are. Physicians want their patients to have the best stories possible. Our promise is to empower physicians with the tools they need to create better stories. We’re on a mission to help turn everyday decisions into everyday triumphs for patients with diseases that are difficult to treat.

Latest News

Drug Pipeline

Chemistry

Paratek has discovered an aminomethylcycline - derived from tetracyclines.

Pipeline Overview

Paratek is developing antibiotics to help to tackle the challenges caused by antibiotic resistance.

Publications

See the strides Paratek is making toward antibiotic progress by reviewing their most recent research.

Presentations

Find out how Paratek is reaching out to audiences.

Learn More About Our Founders

Dr. Walter Gilbert, Ph.D.

In 1996, Dr. Gilbert co-founded Paratek Pharmaceuticals and served as its Chairman until 2014.

Dr. Stuart B. Levy, M.D.

Stuart B. Levy, M.D., is a past President of the American Society for Microbiology (ASM) and co-founder of Paratek Pharmaceuticals, Inc. Dr. Levy has published numerous works about antibiotic use and resistance. In 2005, colleagues honored him with the ASM book: Frontiers in Antibiotic Resistance: a Tribute to Stuart B. Levy.

Talk with the Paratek Team

Send us an inquiry by submitting a form directly on the site or give us a call.